Stoke Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Stoke Therapeutics, Inc. (STOK) reported Basic Shares Outstanding (Weighted Average) of 66.02 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-03
- Stoke Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 66.02M shares, a 13.13% increase year-over-year.
- Stoke Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 63.06M shares, a 8.99% increase year-over-year.
- Stoke Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 62.04M shares, a 8.72% increase year-over-year.
- Stoke Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 58.61M shares, a 4.03% increase year-over-year.
- Stoke Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 59.22M shares, a 9.65% increase from fiscal 2024.
- Stoke Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 54.01M shares, a 22.76% increase from fiscal 2023.
- Stoke Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 43.99M shares, a 13.10% increase from fiscal 2022.
- Stoke Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 38.90M shares, a 5.87% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 66.02M shares 10-Q · filed 2026-08-03 | 64.55M shares 10-Q · filed 2026-08-03 | 63.71M shares derived: average of 3 quarters · filed 2026-08-03 | 62.43M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 63.06M shares 10-Q · filed 2026-05-07 | 62.55M shares derived: average of 2 quarters · filed 2026-05-07 | 61.24M shares derived: average of 3 quarters · filed 2026-05-07 | 60.52M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | 62.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 60.33M shares derived: average of 2 quarters · filed 2026-03-16 | 59.67M shares derived: average of 3 quarters · filed 2026-08-03 | 59.22M shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 58.61M shares 10-Q · filed 2025-11-04 | 58.48M shares derived: average of 2 quarters · filed 2026-08-03 | 58.28M shares 10-Q · filed 2025-11-04 | 57.97M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | 58.35M shares 10-Q · filed 2026-08-03 | 58.11M shares 10-Q · filed 2026-08-03 | 57.76M shares derived: average of 3 quarters · filed 2026-08-03 | 57.41M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | 57.86M shares 10-Q · filed 2026-05-07 | 57.46M shares derived: average of 2 quarters · filed 2026-05-07 | 57.09M shares derived: average of 3 quarters · filed 2026-05-07 | 56.76M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 57.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 56.70M shares derived: average of 2 quarters · filed 2026-03-16 | 56.39M shares derived: average of 3 quarters · filed 2026-03-16 | 54.01M shares 10-K · filed 2026-03-16 |
| 2024-09-30 | 56.34M shares 10-Q · filed 2025-11-04 | 56.05M shares derived: average of 2 quarters · filed 2025-11-04 | 52.99M shares 10-Q · filed 2025-11-04 | 50.83M shares derived: average of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | 55.77M shares 10-Q · filed 2025-08-12 | 51.29M shares 10-Q · filed 2025-08-12 | 48.99M shares derived: average of 3 quarters · filed 2025-08-12 | 47.81M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 46.25M shares 10-Q · filed 2025-05-13 | 45.61M shares derived: average of 2 quarters · filed 2025-05-13 | 45.16M shares derived: average of 3 quarters · filed 2025-05-13 | 44.92M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 44.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 44.62M shares derived: average of 2 quarters · filed 2025-03-18 | 44.47M shares derived: average of 3 quarters · filed 2025-03-18 | 43.99M shares 10-K · filed 2025-03-18 |
| 2023-09-30 | 44.27M shares 10-Q · filed 2024-11-05 | 44.23M shares derived: average of 2 quarters · filed 2024-11-05 | 43.67M shares 10-Q · filed 2024-11-05 | 42.61M shares derived: average of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | 44.19M shares 10-Q · filed 2024-08-07 | 43.37M shares 10-Q · filed 2024-08-07 | 42.05M shares derived: average of 3 quarters · filed 2024-08-07 | 41.40M shares derived: average of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | 42.54M shares 10-Q · filed 2024-05-06 | 40.99M shares derived: average of 2 quarters · filed 2024-05-06 | 40.47M shares derived: average of 3 quarters · filed 2024-05-06 | 40.16M shares derived: average of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | 39.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 39.43M shares derived: average of 2 quarters · filed 2024-03-25 | 39.37M shares derived: average of 3 quarters · filed 2024-03-25 | 38.90M shares 10-K · filed 2024-03-25 |
| 2022-09-30 | 39.42M shares 10-Q · filed 2023-11-07 | 39.34M shares derived: average of 2 quarters · filed 2023-11-07 | 38.72M shares 10-Q · filed 2023-11-07 | 38.24M shares derived: average of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 39.26M shares 10-Q · filed 2023-08-07 | 38.36M shares 10-Q · filed 2023-08-07 | 37.85M shares derived: average of 3 quarters · filed 2023-08-07 | 37.58M shares derived: average of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | 37.45M shares 10-Q · filed 2023-05-04 | 37.14M shares derived: average of 2 quarters · filed 2023-05-04 | 37.01M shares derived: average of 3 quarters · filed 2023-05-04 | 36.94M shares derived: average of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | 36.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 36.80M shares derived: average of 2 quarters · filed 2023-03-06 | 36.77M shares derived: average of 3 quarters · filed 2023-03-06 | 36.74M shares 10-K · filed 2023-03-06 |
| 2021-09-30 | 36.76M shares 10-Q · filed 2022-11-14 | 36.73M shares derived: average of 2 quarters · filed 2022-11-14 | 36.71M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 36.71M shares 10-Q · filed 2022-08-08 | 36.68M shares 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |